Marinus Pharmaceuticals | MRNS - Capital Ordinaire



Capital Ordinaire Changement Date
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
ALKERMES USD 166.46M 855K 2026-03
Amgen USD 540M 1000K 2026-03
Biogen USD 146.7M 200K 2025-09
Eisai JPY 282.11M 0 2026-03
Enanta Pharmaceuticals USD 212K 1000 2023-12
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
Incyte USD 199.95M 1.49M 2026-03
Minerva Neurosciences USD 1000 0 2024-09
Neurocrine Biosciences USD 100.6M 500K 2026-03
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Sarepta Therapeutics USD 105.57M 607K 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
UCB EUR 190.36M 365.15K 2025-12
Vertex Pharmaceuticals USD 254.2M 200K 2026-03